SWAV Shockwave Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SWAV

Price (delayed)

$330.38

Market cap

$12.36B

P/E Ratio

82.39

Dividend/share

N/A

EPS

$4.01

Enterprise value

$12.79B

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for ...

Highlights
Shockwave Medical's revenue has increased by 49% YoY and by 9% from the previous quarter
SWAV's gross profit is up by 49% year-on-year and by 9% since the previous quarter
SWAV's quick ratio has soared by 79% YoY but it is down by 18% from the previous quarter
The P/E is 117% above the last 4 quarters average of 38.0
SWAV's EPS is down by 40% QoQ and by 33% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://shockwavemedical.com
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of SWAV
Market
Shares outstanding
37.4M
Market cap
$12.36B
Enterprise value
$12.79B
Valuations
Price to earnings (P/E)
82.39
Price to book (P/B)
18.23
Price to sales (P/S)
16.61
EV/EBIT
70.61
EV/EBITDA
65.71
EV/Sales
17.52
Earnings
Revenue
$730.23M
EBIT
$181.19M
EBITDA
$194.7M
Free cash flow
$165.46M
Per share
EPS
$4.01
Free cash flow per share
$4.51
Book value per share
$18.12
Revenue per share
$19.89
TBVPS
$39.07
Balance sheet
Total assets
$1.57B
Total liabilities
$897.89M
Debt
$766.97M
Equity
$668.68M
Working capital
$1.12B
Liquidity
Debt to equity
1.15
Current ratio
11.76
Quick ratio
10.61
Net debt/EBITDA
2.25
Margins
EBITDA margin
26.7%
Gross margin
86.9%
Net margin
20.2%
Operating margin
21.8%
Efficiency
Return on assets
12.8%
Return on equity
24%
Return on invested capital
16.9%
Return on capital employed
12.4%
Return on sales
24.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SWAV stock price

How has the Shockwave Medical stock price performed over time
Intraday
0.12%
1 week
0.12%
1 month
3.01%
1 year
17.41%
YTD
73.37%
QTD
1.46%

Financial performance

How have Shockwave Medical's revenue and profit performed over time
Revenue
$730.23M
Gross profit
$634.84M
Operating income
$159.09M
Net income
$147.28M
Gross margin
86.9%
Net margin
20.2%
The net margin has plunged by 54% YoY and by 44% from the previous quarter
Shockwave Medical's revenue has increased by 49% YoY and by 9% from the previous quarter
SWAV's gross profit is up by 49% year-on-year and by 9% since the previous quarter
Shockwave Medical's net income has decreased by 40% from the previous quarter and by 32% YoY

Growth

What is Shockwave Medical's growth rate over time

Valuation

What is Shockwave Medical stock price valuation
SWAV P/E details
P/E
82.39
P/B
18.23
P/S
16.61
EV/EBIT
70.61
EV/EBITDA
65.71
EV/Sales
17.52
The P/E is 117% above the last 4 quarters average of 38.0
SWAV's EPS is down by 40% QoQ and by 33% YoY
SWAV's price to book (P/B) is 36% higher than its last 4 quarters average of 13.4 and 7% higher than its 5-year quarterly average of 17.1
The company's equity rose by 31% YoY and by 11% QoQ
Shockwave Medical's revenue has increased by 49% YoY and by 9% from the previous quarter
The price to sales (P/S) is 44% lower than the 5-year quarterly average of 29.6 but 29% higher than the last 4 quarters average of 12.9

Efficiency

How efficient is Shockwave Medical business performance
Shockwave Medical's return on assets has shrunk by 72% YoY and by 52% QoQ
SWAV's ROE has plunged by 60% YoY and by 43% from the previous quarter
SWAV's ROIC has plunged by 51% YoY and by 25% from the previous quarter

Dividends

What is SWAV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SWAV.

Financial health

How did Shockwave Medical financials performed over time
SWAV's total assets is 74% more than its total liabilities
SWAV's total assets has soared by 142% YoY and by 6% from the previous quarter
SWAV's quick ratio has soared by 79% YoY but it is down by 18% from the previous quarter
The debt is 15% more than the equity
The company's equity rose by 31% YoY and by 11% QoQ
Shockwave Medical's debt to equity has decreased by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.